Aera Therapeutics
Aera Therapeutics is a genetic-medicines biotechnology company founded by a team of scientists, investors, and company builders to unlock the potential of genetic medicines through next-generation delivery technologies and precision payloads. Aera develops multiple proprietary delivery platforms — including Targeted Lipid Nanoparticles (tLNPs) and protein-nanoparticle systems — to broaden the application of genetic medicines across many disease areas, advancing a broad preclinical pipeline toward the clinic. Surfaced as a portfolio company of GV (Google Ventures) and added to the API Evangelist network. Aera is a therapeutics company and publishes no public developer API, portal, or documentation surface; this profile captures its corporate identity and domain-security posture. Sector: life-sciences.
Aera Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Genetic Medicine, and Therapeutics.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API